Hematopoietic stem and progenitor cells (HSPC), that is, the cell population giving rise not only to all mature hematopoietic lineages but also the presumed target for leukemic transformation, can transmit (adverse) genetic events, such as are acquired from chemotherapy or ionizing radiation. Data on the repair of DNA double-strand-breaks (DSB) and its accuracy in HSPC are scarce, in part contradictory, and mostly obtained in murine models. We explored the activity, quality and molecular components of DSB repair in human HSPC as compared with mature peripheral blood lymphocytes (PBL). To consider chemotherapy/radiation-induced compensatory proliferation, we established cycling HSPC cultures. Comparison of pathway-specific repair activities using reporter systems revealed that HSPC were severely compromised in non-homologous end joining and homologous recombination but not microhomology-mediated end joining. We observed a more pronounced radiation-induced accumulation of nuclear 53BP1 in HSPC relative to PBL, despite evidence for comparable DSB formation from cytogenetic analysis and γH2AX signal quantification, supporting differential pathway usage. Functional screening excluded a major influence of phosphatidylinositol-3-OH-kinase (ATM/ATR/DNA-PK)-and p53-signaling as well as chromatin remodeling. We identified diminished NF-κB signaling as the molecular component underlying the observed differences between HSPC and PBL, limiting the expression of DSB repair genes and bearing the risk of an inaccurate repair.
INTRODUCTION
The administration of ionizing radiation or chemotherapeutics have been shown to lead to therapy-related leukemia. 1, 2 At which stage of leukemia development radiation or chemicals act and what the underlying mechanisms are remain to be fully elucidated, especially for the human beings. Radiation and chemical agents can cause several types of DNA damage and mammalian cells are equipped with distinct mechanisms for damage removal. 3 However, errors occurring during DNA repair can lead to the accumulation of mutations, gene or chromosomal rearrangements and ultimately transmission of altered genetic information to the damaged cells' progeny. 4, 5 This applies notably to hematopoietic stem and progenitor cells (HSPC), which are targeted and as a consequence depleted by administration of chemotherapeutics or radiotherapy. 6, 7 Surviving, potentially aberrant HSPC following the acquisition of mutations are most likely the cells of origin for leukemia, even though the precise location of the leukemia-initiating cell within the hierarchical hematopoietic tree remains a matter of debate. 8, 9 Amongst all types of DNA damage, the most critical lesions are DNA double-strand-breaks (DSB), which are repaired either by non-homologous end joining (NHEJ) or by homologous repair. Canonical NHEJ is partially error free, 10 whereas microhomology-mediated end joining (MMEJ) utilizes microhomologies, which may arise after resection of the broken ends. Therefore MMEJ is error prone. 11 Homologous recombination (HR), that is, conservative homologous repair, also requires end processing. However, when involving perfectly homologous sequences, it accurately repairs DSB. Non-conservative homologous repair, in particular single-strand annealing (SSA), requires an extensive processing of the broken DNA ends before annealing between repeats, resulting in the loss of intervening sequences, and hence in the disruption of genomic integrity. 3 As the fidelity differs, the choice of the DSB repair pathway has a key role in the maintenance of genomic integrity. The cell cycle stage has been implicated in the pathway choice. Evidence provided from the mouse models suggested that HSPC employ error-prone NHEJ to repair damage during quiescence, whereas upon stimulation actively cycling HSPC use high-fidelity HR. 12, 13 Altogether, data regarding DSB repair accuracy in HSPC are scarce, in part contradictory, and were obtained almost exclusively in murine model systems. [12] [13] [14] However, rodent and human cells differ in radiation-induced DSB repair and checkpoint control activities. [15] [16] [17] In our study we aimed to compare the activity, quality, and molecular components of DSB repair in human CD34+ HSPC and mature hematopoietic cells (peripheral blood lymphocyte (PBL)). We chose PBL as they represent an extensively studied system for mature hematopoietic cells (hence a positive control of sorts) and are generally considered a reliable biomarker of radiation late effects. 18, 19 In the organism, both HSPC and PBL are mostly in the G0/G1-phase, except upon stimulation, for example, upon compensatory proliferation of HSPC after bone marrow irradiation. 20 As the whole spectrum of DSB repair pathways with different fidelities can be found only in actively cycling cells, cycling was induced with hematopoietic growth factors in our ex vivo study. DSB were induced by using ionizing irradiation (Xrays, γ-rays) or targeted cleavage by I-SceI-meganuclease. To assess DSB repair in HSPC and PBL mechanistically, a pathwayspecific reporter system, cytogenetic analysis of induction and repair of radiation-induced breaks and detection of DNA damage markers were employed. To unravel the molecular basis, functional screening of signaling and chromatin remodeling factors was performed identifying the transcription factor NF-κB as the molecular component which has a role in the differential activation of DSB repair pathways between HSPC and PBL.
MATERIALS AND METHODS
Sample collection and primary cell culture, cell cycle and apoptosis Primary hematopoietic cells were isolated from peripheral blood or G-CSF mobilized donor apheresis products of healthy volunteer donors. Donors were recruited and samples obtained with informed consent by the Department of Cellular Therapeutics/Cell Processing of the German Red Cross Blood Center Frankfurt or at the Department of Gynecology and Obstetrics at Ulm University. The study was approved by the local advisory boards (approvals #329/10;#157/10;#155/13).
HSPC were CD34+ enriched, cultured for 72 h and irradiated as described. 21 Cell cycle distribution and apoptosis-induction were determined by flow cytometric analysis essentially as before. 22 See also Supplementary Information.
Cellular sensitivity to radiation exposure and PARP inhibition
Cell viability following X-ray exposure (0.5 Gy-8 Gy) or treatment with poly (ADP-ribose)polymerase inhibitor 1,5-Isoquinolinediol (IQD; Calbiochem, Darmstadt,Germany; 2-2000 μM) were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay as described. 23 Cytogenetic and flow cytometric analysis of chromosome breaks Radiation-induced chromosome breaks were analyzed after premature chromosome condensation as described. 24 Total cellular γH2AX signals were quantified as detailed in Supplementary Information.
Quantitative immunofluorescence microscopy
At different time points post irradiation (1-24 h), cells were spun on cover slips, and processed for immunofluorescence microscopy as described. 22 Antibodies are listed in Supplementary Information. Immunofluorescence signals were visualized by an Olympus BX51 epifluorescence microscope equipped with an Olympus XC10 camera and acquired images automatically analyzed by CellF2.5_analysis software including the mFIP software (Olympus Soft Imaging System, Münster, Germany) or by a Keyence BZ-II Analyzer (Keyence, Neu-Isenburg, Germany). NF-κBinhibitor Disulfiram (Sigma-Aldrich, Steinheim, Germany) was added for 2-4 h before irradiation at the indicated concentrations.
Fluorescence-based analysis of DSB repair pathways
Pathway-specific DSB repair analysis was performed essentially as described. [25] [26] [27] For further details including assay conditions after 53BP1, PARP1 or p53 knockdown, expression of IκBα superrepressor and ATM/ATR kinase-inhibition see Supplementary Information.
NF-κB reporter assay
Transcriptional NF-κB activity was measured under the conditions of the DSB repair assay by using a reporter plasmid for NF-κB-dependent GFP production (pTRF-NF-кB-dscGFP) as described. 22 
Immunoblotting
Immunoblotting of cellular protein lysates and chemiluminescence detection were performed as described. 22 Antibodies are listed in Supplementary Information western blot signals were visualized and quantified in the linear range subtracting background signals by a ChemiDoc MP System equipped with ImageLab 4.0 Software (BioRad, München,Germany).
RESULTS
Ex vivo model systems for the analysis of the DSB response in human HSPC and PBL Error-prone DSB repair activities are thought to be responsible for generating chromosomal rearrangements that can lead to hematopoietic malignancies. 14 Since HSPC likely are the origin of radiation-induced leukemogenesis, 28 we performed a systematic analysis of DSB repair activities in these primitive hematopoietic cells versus differentiated PBL. CD34+ HSPC and PBL were obtained from the same donors and from age-and sex-matched volunteers. 21, 27 To verify comparability of HSPC and PBL, we monitored cell cycle distribution and cell death during ex vivo expansion and following radiationinduced DSB formation. As depicted in Figure 1a , PBL and HSPC were similarly released from G1-into S-and G2-phase 48-72 h after the start of ex vivo stimulation with a residual G1-fraction of 60% in both cell types. Treatment of cells with 2 Gy of X-rays after cultivation for 72 h resulted in~50% compared with~60% of G1-phase cells in mock-treated cells. As shown in Figure 1b , analysis of SubG1-DNA content demonstrated cell death of 10-20% in both cell types during ex vivo culture and up to 24 h after irradiation (96 h cultivation in total). Within 48 h of cultivation post irradiation (120 h) 30-40% of PBL and HSPC had died. Statistically significant differences between PBL and HSPC were only detected after irradiation, namely at 78 h for cell cycle distribution (25% versus 21% G2-phase, P = 0.030) and for apoptosis at 78 h (11% versus 10%, P = 0.039) and 120 h (28% versus 35%, P = 0.018). As for analyzing the DSB response most of the cells should be viable and actively cycling after a cultivation period of 72 h and for another 24 h post irradiation. Thus, DSB were induced in HSPC and PBL either by irradiation or cleavage with I-SceI meganuclease and repair activities analyzed in this time frame.
HSPC show pathway-specific DSB repair deficiency
To investigate specific DSB repair mechanisms, we applied a panel of EGFP-based reporter substrates designed for measurements of NHEJ, 26 MMEJ, homologous repair, that is, both conservative HR and non-conservative SSA, and HR 25 following I-SceI meganuclease-mediated cleavage (Figure 2a ). To consider the length of uninterrupted homologies between the EGFP variants undergoing homologous exchange, we engaged substrates with 200 bp long (HR-EGFP/3´EGFP, HR-EGFP/5´EGFP) versus shortened homologies (ΔEGFP/3´EGFP, ΔEGFP/5´EGFP) 5´to the I-SceI site. Cycling HSPC and PBL as well as control lymphoblastoid cell line (LCL) were subjected to nucleofection with the different substrates together with I-SceI expression plasmid and reconstitution of wild-type EGFP measured by flow cytometry 24 h later. Each quantification of green fluorescent cells in repair assays was normalized by use of the individually determined transfection efficiency to calculate the DSB repair frequency.
The results revealed 10-and 22-fold lower NHEJ frequencies in HSPC compared with LCL and PBL, respectively ( Figure 2b ). Here, we engaged substrate EJ5SceGFP, which monitors all NHEJ events, that is, both simple rejoining between two cleaved I-SceI sites as well as error-prone events accompanied by deletion or insertion of nucleotides. 26 However when focusing on error-prone MMEJ by use of EJ-EGFP, 25 we did not detect statistically significant differences between these cell types ( Figure 2c ). Homologous repair using substrate HR-EGFP/3´EGFP (long homologies) was fourfold reduced in HSPC versus both LCL and PBL ( Figure 2d ). By using ΔEGFP/3´EGFP (short homologies) it was 17-and 12-fold reduced in HSPC versus LCL and PBL, respectively. HR frequencies in HSPC were 17-and fivefold lower for HR-EGFP/5´EGFP (long homologies) and 20-and 16-fold lower for ΔEGFP/5´EGFP (short homologies) as compared with LCL and PBL, respectively (Figure 2e ). Analysis of cell cycle and viability did not reveal differences between HSPC and PBL under the conditions of DSB repair measurements ( Supplementary Figure 1 ). Thus HSPC were less active in all DSB repair activities except MMEJ. Largest differences were found for NHEJ and HR involving short homologies.
Sensitivities to genotoxic treatment reflect compromised DSB repair activities in HSPC To examine the capacity of HSPC and PBL to remove DNA lesions by using an independent approach, we assessed cell viability following radiation exposure or PARP inhibition. Treatment with X-ray induces DSB that are primarily repaired by NHEJ. Inhibition of PARP compromises various DNA repair mechanisms resulting in replication arrest and a severe dependency on HR-mediated fork reactivation. 29 Both following radiation exposure and after PARP inhibition metabolic activities of HSPC and PBL decreased with increasing doses. The calculated ID50 revealed a 2.7-fold lower value for HSPC as compared with PBL (Table 1) , consistent with the lower repair capacity indicated by NHEJ reporter measurements. In line with the reporter measurements revealing compromised HR in HSPC versus PBL, they showed a higher sensitivity to PARP inhibition with a 6.7-fold reduced IC50-value.
For comparison, we used reference LCL to test the influence of BRCA2 mutations on survival and measured 1.6-fold lower ID50/1.5-fold lower IC50-values for HA238 with monoallelic BRCA2 mutation after X-ray/PARP inhibitor (PARPi)-treatment as compared with the wild-type control TK6. GM13023A with biallelic BRCA2 mutations showed extreme sensitivity to PARP inhibition with an IC50-value 1-2 orders of magnitude below the control. The greater sensitivities to radiation and PARPi-treatment of HSPC versus PBL therefore confirmed their NHEJ and particularly HR deficiency.
DSB processing differs in HSPC as compared with PBL To dissect the molecular events during the DNA damage response of HSPC versus PBL, we comparatively analyzed critical DSB repair components following irradiation with 2 Gy of photons. [30] [31] [32] First, we monitored radiation-induced formation and removal of DSB applying the cytogenetic method of premature chromosome condensation. Second, we analyzed breakage and subsequent repair within the chemo-and radiosensitive MLL breakpoint cluster region (MLLbcr) by genomic PCR. We observed similar responses in both cell types with respect to the initial For the evaluation of NHEJ we employed plasmid EJ5SceGFP with two tandem I-SceI cutting sequences encompassing a spacer sequence separating the transcriptional promoter from the EGFP coding sequence. 26 To measure MMEJ we used substrate EJ-EGFP consisting of a mutated EGFP gene, in which an I-SceI cleavage site is integrated and flanked by 5 bp sequence repeats. 25 Acceptor EGFP gene variants for homologous DSB repair were designed as follows: 25 To the contrary, when we quantified nuclear foci specific for 53BP1, another early marker of DSB and important regulator of DSB signaling, we scored 3.1-fold higher 53BP1 foci numbers in HSPC versus PBL 1 h post irradiation, respectively, that is, before the decline to background levels until 6 h post irradiation (Figures 3e and f) . Similarly, we counted 3.5-fold more 53BP1 foci in HSPC versus LCL (416MI) 1 h post irradiation (data not shown). Upon DSB end processing RPA coats single-stranded DNA overhangs followed by phosphorylation of the 32 kDa subunit (pRPA). 33 NF-кB-signaling differentially promotes DSB repair in HSPC and PBL Previous work on human hematopoietic stem cells had revealed roles of the tumor suppressor p53 in radiation-induced apoptosis and in hematopoietic stem cells self-renewal independently of apoptosis. 34 In addition, several groups had reported that p53 represses and controls the fidelity of HR. 35 Therefore, we examined the consequences of p53 depletion on cell type-specific homologous repair (Figure 4a ). Knockdown of p53 via introduction of expression plasmid for p53-specific shRNA abrogated p53 expression in PBL and HSPC (Figure 4b ). Consistent with the inhibitory role of p53, 25 p53 knockdown raised the homologous repair frequency with substrate ΔEGFP/3´EGFP 1.8-fold in PBL ( Figure 4a ). In HSPC, p53-specific shRNA did not significantly affect homologous repair, most likely due to the extremely low endogenous level of p53 in these cells (Figure 4b ). Distinctive functions of p53 in the two cell types, therefore, did not offer an explanation for the observed differences in homologous repair. Moreover, shRNA specific for 53BP1 did neither alter homologous repair in PBL nor in HSPC (data not shown).
Next we investigated the impact of central damage-signaling pathways mediated by the phosphatidylinositol-3-OH-kinase-like family members (PI3K) ATM and ATR and by the break sensor PARP1. 29, 30 While treatment of cells with the ATM/ATR kinaseinhibitory drug Caffeine had no significant effect on homologous repair in both PBL and HSPC ( Supplementary Figure 3) , shRNAbased knockdown of PARP1 reduced the frequency in PBL by 39% (Figures 4c and d) . Homologous repair in HSPC remained unaffected suggesting a contribution of PARP1 to the elevated activity in PBL. PARP1 has been identified as an important component of NF-κB pathway activation in response to genotoxic stress, 36 and accumulating evidence has been provided for a critical involvement of NF-κB in DSB repair. 22,37-39, Consequently, we asked whether inhibition of NF-κB activation by expression of a superrepressor variant of IκBα (IκBα-SR) 22 alters DSB repair in these cell types. Similarly as for PARP1 knockdown, IκBα-SR expression ( Figure 4g ) caused a 33% reduction of homologous DSB repair in PBL without an effect on HSPC (Figures 4e and g) . Knowing that NF-κB promotes both HR and NHEJ, 22, 37, 38 that is, the mechanisms showing different activities in PBL and HSPC, we also analyzed NHEJ after IκBα-SR expression. Different from homologous repair, NHEJ was compromised in both cell types leading to a reduction of the initial frequencies down to 52% in PBL and to 37% in HSPC (Figure 4f ). Recently, Porteu and co-workers 40 observed that different growth factors, TPO in particular, promoted NHEJ in HSPC (approximately twofold). Based on their results, they proposed a mechanism according to which TPO induces DNA-PK phosphorylation via stimulation of ERK kinase and additionally promotes damageinduced transcription of the DNA-PK binding partner IEX-1, encoded by the NF-κB target Iex-1. Inclusion of TPO into human HSPC cultures did neither cause a statistically significant change in homologous repair (P = 0.7302) nor in NHEJ (P = 0.1520) ( Figures  4h and i) . Therefore, lack of growth factor-mediated signaling in HSPC was unlikely to explain the 16-fold and 22-fold reduced homologous repair and NHEJ frequencies, respectively, that we had observed in human HSPC versus PBL (Figure 2 ).
NF-кB-inhibition augments 53BP1 foci formation in PBL but not HSPC
Having established that NF-κB activation was required for fully efficient homologous repair in PBL but not in HSPC, we asked whether changes in NF-κB-signaling were also underlying the observed differences in DSB processing downstream of γH2AX foci assembly (Figure 3 ). To this end we determined 53BP1 foci numbers 1 h post irradiation in PBL and HSPC cultures during exposure to the NF-κB-inhibitor Disulfiram. 41, 42 Strikingly, Disulfiram concentrations in the range of 0.2-4 μM caused a 2-3-fold increase of 53BP1 foci numbers in PBL but no further increase of radiation-induced foci in HSPC (Figure 5a and b) . Disulfiramtreatment without additional irradiation induced 53BP1 foci in both cell types ( Supplementary Figure 4) , most likely reflecting accumulation of replication-associated damage due to a defect in HR-mediated bypass of stalled forks. 22 Disulfiram-treatment did neither influence the cell cycle distribution of PBL nor of HSPC (Supplementary Figure 5 ). NF-κB pathway inhibition by IκBα-SR expression in immortalized lymphocytes (LCL 416MI) induced 2.2-fold more radiation-induced 53BP1 foci ( Figure 5c ) supporting our findings with Disulfiram-treated primary lymphocytes (PBL), which were too fragile for corresponding experiments. 53BP1 was reported to detect changes in chromatin conformation in the vicinity of DSB including ATM-triggered histone modification, chromatin PARylation and histone deacetylase (HDAC)1/2-mediated histone deacetylation. 32, 43 Pharmacological inactivation of PI3K known to phosphorylate H2AX upstream of 53BP1 recruitment to DSB, 30, 31 namely ATM/ATR by Caffeine and DNA-PK by NU7441 separately or concomitantly ( Supplementary  Figure 6a ,b,c) as well as of PARP by IQD ( Supplementary Figure 6d ) caused comparatively small changes (r 20%) in 53BP1 foci numbers following irradiation. Concomitant exposure to ATM/ ATR, DNA-PK, and PARPi reduced 53BP1 foci accumulation by 34-36%, however, in both PBL and HSPC ( Supplementary  Figure 6d ). Exposure to the HDAC-inhibitor Trichostatin A reduced 53BP1 foci numbers in irradiated PBL by 41%, that is, enlarged rather than diminished the difference between PBL and HSPC ( Supplementary Figure 6f) . The epigenetic modulator Aza-dC, which induces genome-wide DNA hypomethylation, showed a minor effect of~20% foci number reduction in PBL. Similarly as with Disulfiram exposure, most of these drug-treatments caused an increase of 53BP1 foci numbers in non-irradiated PBL and for IQD and Trichostatin A also in HSPC, again suggestive of replication stress-induced DNA damage. Collectively, our data revealed that inhibition of NF-κB but not of any other signaling pathway raised 53BP1 foci numbers in irradiated PBL to the level observed for HSPC suggesting that active NF-κB prevents 53BP1 foci assembly in PBL.
HSPC show reduced expression of DSB repair-related NF-кB target gene products
Our experiments employing IκBα-SR and Disulfiram indicated an epistatic relationship between NF-κB activity and homologous repair as well as repression of 53BP1 foci accumulation in PBL. To understand whether PBL and HSPC differ in NF-κB signaling, we measured transcriptional activities using a GFP-based reporter revealing 2-12-fold higher NF-κB activity in PBL versus HSPC (Figure 6a, Supplementary Figure 7) . Expression of the superrepressor IκBα-SR reduced NF-κB activity twofold in PBL ( Supplementary Figure 7) . Next, we analyzed expression of endogenous proteins known to be transcriptionally regulated by NF-κB (http://people.bu.edu/gilmore/nf-kb/). [37] [38] [39] Consistent with higher transcriptional activity in PBL, we observed twofold elevated mean protein levels of IκBα, ATM, and BRCA2 and a similar trend for KU70 (Figure 6b and c) . To the contrary, PBL showed lower levels of the KU70-and BRCA2-complex partner DNA-PKcs and RAD51, respectively. The NF-κB-subunit p65 was equally expressed in both cell types. Despite increased PARPi sensitivity (Table 1) HSPC showed fivefold higher endogenous PARP1 levels. Even though 53BP1 and pRPA foci numbers were elevated in HSPC (Figure 3e,f,g and h) , total amounts of 53BP1 and the 32 kDa subunit of RPA were below or similar in HSPC versus PBL, indicating functional rather than expression changes underlying differential foci formation. Altogether, we observed a significant difference in NF-κB signaling between PBL and HSPC including changes in the expression of the critical homologous repair proteins ATM and BRCA2. To provide direct evidence for downregulation of key repair protein expression in PBL after NF-κB pathway inhibition, we performed corresponding western blot analysis. The results indeed revealed a 40% decrease of both ATM and KU70 in PBL following IκBα-SR expression under the conditions of DSB repair measurements (Figure 6d) .
DISCUSSION
Cells at a high replication frequency such as multipotent hematopoietic progenitor cells undergoing compensatory proliferation following radiation or chemotherapeutic treatment are prone to replication fork stalling and ultimately DSB formation. 44 So far, only little information was available on the fidelity of DSB repair in HSPC, underscoring the need for the systematic analysis of capacity, pathway usage, and quality of DSB repair in cycling human CD34+ HSPC undertaken in our work.
In agreement with the concept that HSPC are more susceptible to leukemogenic genome rearrangements than terminally differentiated cells 14 we observed a relative rise of error-prone NHEJ in human HSPC versus PBL. Thus, when using a reporter enabling detection of mutagenic MMEJ, repair frequencies were not significantly different in HSPC and PBL. However, with substrate detecting total NHEJ, that is, error-free rejoining as well as events associated with nucleotide changes, we measured 22-fold lower repair frequencies in HSPC versus PBL. Homologous repair (SSA plus HR), was performed at up to 12-fold lower frequencies in HSPC versus PBL, whereby HR, that is, predominantly gene conversion, was most severely affected (up to 16-fold lower frequencies). This observation suggested relative preference of error-prone SSA rather than high-fidelity gene conversion during homologous repair in human HSPC. Notably, previous data indicated involvement of not only MMEJ but also SSA in reciprocal translocations in murine progenitor cells. 14 Differences between homologous repair in HSPC and PBL were most pronounced when the length of homology adjacent to the I-SceI-site was short. Applying the same substrates, we previously demonstrated that DNA exchange between short stretches of homologies is suppressed by mismatch repair proteins and p53 to prevent genomic instability. 25, 45 Expression and functionality of the mismatch repair components MSH2 and MLH1 were described for human HSPC. 46 Our protein expression and knockdown data excluded a role of p53 in the fidelity control of HR in HSPC. However, we noticed an inverse RAD51/BRCA2 expression pattern in HSPC versus PBL with high RAD51 and low BRCA2 levels in HSPC. Similarly, Stambrook and co-workers 47 observed abundance of endogenous Rad51 but not of replication or cell cycle control proteins in murine embryonic stem cells versus mouse embryonic fibroblasts, which was thought to explain predominance of HR versus NHEJ. In murine embryonic stem cells-derived hematopoietic progenitors overexpression of Rad51 was found to specifically promote long-tract gene conversion events associated with loss-of-heterozygosity and tandem duplications. 14 Further, BRCA2-deficiency in hamster cells was reported to affect shorttract gene conversion in particular, while maintaining proficiency in sister chromatid exchange. 48 A high RAD51/BRCA2 ratio, as was observed here in human HSPC, and induction of long-tract gene conversion events therefore provides another explanation for the bias toward HR with long homologies. HR is known to be required for the survival of HSPC as underscored by bone marrow failure in Fanconi anemia patients. 49 Gerson and co-workers 50 recently confirmed the critical role of HR in DNA damage processing and survival of nonquiescent HSPC by use of an Exo1 mutant mouse model. However, even HR may increase the risk of genome rearrangements such as via loss-of-heterozygosity.
Most of our findings regarding various DSB repair changes in HSPC were reconciled, when we discovered reduced canonical NF-κB activity by use of a transcriptional reporter. Previous work identified NF-κB as a component of a DSB signaling pathway initiated by PARP1 and ATM, leading to phosphorylation of the regulatory I κB kinase (IKK) subunit NEMO, subsequent I κBα phosphorylation and degradation, and ultimately nuclear translocation of the NF-κB-subunit p65 for transcription. 36 Of interest for our work, transcriptional NF-κB targets include KU70, BRCA2, and ATM (http://www.bu.edu/nf-kb/gene-resources/targetgenes/). [37] [38] [39] Low levels of these gene products as well as of the target IκBα are explainable by reduced NF-κB activity in HSPC. In agreement with our data, Bracker and colleagues 51 detected a statistically significant increase of ATM mRNA in mature (CD34-) versus progenitor (CD34+) cells from human cord blood. ATM is the master regulator of the DSB response and assures efficient and high-fidelity homologous repair via signaling to proteins such as MRE11, RAD50, Nibrin, CtIP, BRCA2, and BRCA1. 30, 39, 52, 53 However, ATM/ATR-inhibition by Caffeine did neither affect homologous repair in HSPC nor in PBL arguing against ATM as a limiting factor. Nevertheless, the Caffeine-induced small increase of 53BP1labeled DSB suggested contribution to DSB removal in PBL but not HSPC matching reduced ATM levels in HSPC. Severe homologous repair dysfunction in HSPC can be explained by the combined deficiency of ATM and the RAD51 loading factor BRCA2 together with reduced activation of the BRCA1/CtIP end processing complex, which altogether are known consequences of compromised NF-κB activity. 22 Indeed, we demonstrated a critical role of NF-κB and its upstream signaling component PARP1 in homologous repair in PBL versus HSPC by inhibition and knockdown, respectively. Pharmacological PARP inhibition slightly raised basal 53BP1 foci numbers particularly in HR-deficient HSPC and caused higher cytotoxities in these cells, most likely because PARP1 also prevents accumulation of replication fork stalling lesions. 29, 44 Along this line, Bracker and colleagues found higher sensitivity of cycling ex vivo cultures of human progenitor cells compared with mature cells to Cisplatin-treatment, that is, an agent which generates DNA crosslinks, which like PARPi-induced replication lesions require HR for repair. 51, 54 Supporting the notion that NF-κB signaling represents the key to differential DSB repair pathway usage in HSPC, we noticed striking similarities between HSPC and NF-κB-deficient cells including a modest effect on MMEJ and SSA compared with HR or NHEJ. 22, 38 Even though we found a correlation between reduced Figure 5 . Effect of NF-κB inhibition on radiation-induced 53BP1 foci formation. PBL and HSPC were treated with the NF-κB-inhibitor Disulfiram at the indicated concentrations (0.2, 2, 4 μM) or mocktreated with DMSO for 4 h and afterwards exposed to 2 Gy γ-rays (a, b). Alternatively, NF-κB was inhibited in immortalized lymphocytes (LCL 416MI) by nucleofection with IκBα-SR expression plasmid and irradiated 24 h later (c). Following a 1 h recultivation period the cells were fixed and 53BP1 immunocytochemically detected in all cells (a, b) or cells showing green fluorescence due to cotransfection with wild-type EGFP expression plasmid, respectively NF-κB, HR, and NHEJ activities in HSPC versus PBL, inhibition of NF-κB downregulated NHEJ in both PBL and HSPC but homologous repair in PBL only. These results suggested that residual NHEJ required the remaining NF-κB activity in HSPC, whereas residual homologous repair was NF-κB-independent. This indicated a limiting step in NF-κB-induced homologous repair. Because DSB repair assays were performed with extrachromosomal substrates, we concluded that this step must be chromatinindependent. Analysis of DSB in HSPC and PBL by premature chromosome condensation argued against differences in chromosomal breakage following ionizing radiation-treatment. Moreover, low ATM levels in HSPC did not differentially affect H2AX phosphorylation post irradiation, likely due to compensatory activities by ATR and/or DNA-PK. Strikingly however, HSPC showed a sharp rise of 53BP1 foci post irradiation and a subsequent repairrelated decline. This 53BP1 foci peak was not observed in PBL unless treated with a pharmacological NF-κB-inhibitor. Because numerous reports identified 53BP1 together with RIF1 in a DNA end-binding complex antagonizing homologous repair particularly in case of compromised BRCA1 function, 32 pronounced 53BP1 foci formation at DSB in HSPC may be a consequence of reduced NF-κB-mediated BRCA1/CtIP activation. 22 pRPA foci followed the 53BP1 foci patterns in HSPC and PBL, indicating an efficient ssDNA accumulation in HSPC possibly involving EXO1rather than BRCA1/CtIP-mediated end resection. 50,55 RAD51 foci kinetics in HSPC deviated less markedly from the kinetics in PBL (as compared with 53BP1 or pRPA) despite fourfold higher RAD51 level in HSPC. This observation was compatible with limiting BRCA2 levels, as BRCA2 targets RAD51 to ssDNA and facilitates displacement of RPA. 32 Without efficient RAD51 loading RAD52 promotes SSA. 56 Altogether our foci kinetics and immunoblotting data supported our findings with DSB repair assays revealing reduced homologous repair and a relative shift from HR to SSA in HSPC. Limiting BRCA1 and BRCA2 activities are likely to represent critical decision makers for pathway choice in HSPC with low NF-κB activity. Rearrangements of the MLL gene (myeloid/lymphoid or mixedlineage leukemia) are found in 6-35% of treatment-related acute leukemia and 80% of childhood acute lymphoblastic leukemia and were recently discovered to involve endonucleolytic cleavage in response to replication stress. 57, 58 Notably, replication stress in hematopoietic stem cells may stem from excessive self-renewal such as during serial transplantation as well as from treatmentinduced compensatory proliferation. The pattern of MLL rearrangements ranges from chromosomal translocations to complex rearrangements 59 indicating the involvement of both MMEJ as well as homologous repair pathways. In irradiated and clonally expanded HSPC, we detected in almost half of the colonies transmissible aberrations whereas in control populations no clonal aberrations have been observed (unpublished results). Indicating the potential mechanism underlying these aberrations, our work shows that reduced NF-κB activity makes HSPC particularly vulnerable to DSB-induced genome rearrangements due to low NHEJ and HR capacities coupled with a relative more frequent usage of low-fidelity MMEJ and to a lesser extent also SSA. Interestingly, leukemic stem cells were shown to differ from hematopoietic stem cells in that they have constitutively active NF-κB triggering clinical trials which target this pathway in combination with chemotherapy. 60 Our data support the concept that combined treatment with NF-κB-inhibitor could break resistance of leukemic stem cells to genotoxic chemotherapy via DNA repair downregulation. However, it may also bear the risk of secondary mutations from alternative low-fidelity repair and thus create a novel reservoir for the generation of relapsed disease. Future efforts for the development of personalized treatment strategies may therefore aim at risk prediction of leukemogenic genome rearrangements and/or the identification of inhibitors targeting low-fidelity DNA repair pathways.
